Manfred Welslau, Dr. - Clinical Trial Investigator | Syfrah

Trials Sponsors Conditions Drugs Pricing

Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

OTHER(1)

eHealth system support for symptom management via CANKADO

1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1

PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03911219Completed

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBCExtensive-stage Small Cell Lung CancerStage IV Non-small Cell Lung Cancer

PrincipalinvestigatorStart date: 2019-07-10

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

CO

High-influence Collaborator

CO

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC1 Extensive-stage Small Cell Lung Cancer1 Stage IV Non-small Cell Lung Cancer1

Affiliations

MVZ am Klinikum Aschaffenburg

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ido Wolf, MD

Tel-Aviv Sourasky Medical Center

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score10%

Antony Magliocco, MD

Protean BioDiagnostics

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score10%

Eugenie Younger, MD

Gloucestershire Hospitals NHS Foundation Trust

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score10%

Andreas Polychronis, MD

Mount Vernon Cancer Centre

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score10%

Adam Berger, MD

Rutgers Cancer Institute

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score10%

Astrid Ammendola, MD

Asklepios Klinik Gauting GmbH

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score10%

Igor Puzanov, MD

Roswell Park

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score10%

Louise Medley, MD

Torbay and South Devon NHS foundation

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score10%

Andrew Conn, MD

Bradford Teaching Hospitals

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score10%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03911219PrincipalInvestigator

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBCExtensive-stage Small Cell Lung CancerStage IV Non-small Cell Lung Cancer

Completed

All 1 trials loaded